Compare IART & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IART | GRDN |
|---|---|---|
| Founded | 1989 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | Medical/Dental Instruments | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.1M | 2.4B |
| IPO Year | 1996 | N/A |
| Metric | IART | GRDN |
|---|---|---|
| Price | $9.30 | $38.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $14.50 | ★ $39.00 |
| AVG Volume (30 Days) | ★ 733.8K | 558.7K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | N/A |
| Revenue Next Year | $3.40 | $7.14 |
| P/E Ratio | ★ N/A | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $19.17 |
| 52 Week High | $19.25 | $39.18 |
| Indicator | IART | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 64.56 |
| Support Level | $8.70 | $27.36 |
| Resistance Level | $9.91 | N/A |
| Average True Range (ATR) | 0.42 | 1.56 |
| MACD | 0.09 | 0.25 |
| Stochastic Oscillator | 43.84 | 88.15 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.